No Data
No Data
Express News | Fed's Goolsbee Tells CNBC 'nice' to Get Inflation Number That's Better Than Expected
Fennec Pharmaceuticals Brief: Announcing Pedmarqsi "Positive Recommendation" by NICE for Prevention of Cisplatin-Induced Hearing Loss in England and Wales
Fennec Pharmaceuticals Announces Pedmarqsi Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
NICE Shares Are Trading Lower After Jefferies Downgraded the Stock From Buy to Hold and Cut Its Price Target From $215 to $200.
NICE Cut to Hold From Buy by Jefferies
Express News | Jefferies Downgrades NICE to Hold, Lowers Price Target to $200